The UK is the first in the world to license the CRISPR gene editing tool for the treatment of…
In 2020, scientists Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for developing the genome editing method, and three years later, the tool was licensed for the treatment of sickle cell disease and…